UK
Weight Management
Introducing groundbreaking support for your weight management journey. This new programme from HANX combines weekly... Read more
Introducing groundbreaking support for your weight management journey. This new programme from HANX combines weekly doses of clinically proven GLP-1 medication, alongside nutrition and movement guides, to set you up to successfully meet your health goals.
Weight management medication is designed for long-term use with ongoing monitoring. This programme is a fully future-focused subscription, offering safe, effective medication, plus ongoing support, for sustainable results. Programme pricing starts at £180. Learn how it works here.
Whether you're focused on navigating menopausal weight changes, managing symptoms of health conditions such PCOS or exploring the broader wellness benefits of weight loss, Mounjaro (tirzepatide) and Wegovy (semaglutide) are proven, effective solutions for helping you lose weight when combined with a balanced diet and increased exercise.
Effectiveness
- Clinical studies have shown that people can lose up to 22.5% of their weight when taking Mounjaro.*
- Clinical studies have shown that people can lose up to 15% of their weight when taking Wegovy.**
*Tirzepatide Once Weekly for the Treatment of Obesity, The New England Journal Of Medicine, 2022.
**the STEP trial, The New England Journal of Medicine, 2021.
Side Effects:
As with all medication, there are potential side effects with weight loss medication, the most common of which include nausea, diarrhoea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain. These side effects may be temporary, lasting anywhere from a few days to a few weeks, and there are ways you can help manage these. If you do experience any side effects, report these as part of your follow-up consultations and if these are bothersome don't hesitate to get in contact at hello@hanx.co.uk.
Free Q&A: Everything You Need To Know About GLP-1 Medication
Just announced: join HANX Co-Founder and women's health expert, Dr Sarah Welsh for a free digital Q&A. Learn all about Wegovy and Mounjaro, the groundbreaking GLP-1 medication featured in this weight management programme. From the science of how it supports weight loss, to its fascinating potential when it comes to PCOS, get virtual front row to learn more and ask questions.
SIGN UP NOW
How Does Pricing Work On The Programme?
Ready to take the first steps towards your health goals? Our transparent pricing structure ensures you know exactly what you're paying each month, with no hidden fees or surprises. Whether you're considering the benefits of Mounjaro (tirzepatide) or Wegovy (semaglutide), here's a breakdown of the pricing structure of the weight management programme at HANX.
Learn moreEach monthly treatment plan includes
Safe and effective
Treatment is prescribed by a prescribing pharmacist based on what is safe and appropriate for you
Convenient service
Monthly deliveries straight to your door, in plain, unbranded packaging for discretion and peace of mind
Clinic support
Monthly digital check-ins and support from your prescribing pharmacist as and when you need it
10-week meal and exercise plans
Lifestyle advice to help you sustainably achieve a healthy weight for you
Safe and effective medication
NHS approved
UK registered Pharmacy
NICE
What to expect
Start your journey
You’ll take our online consultation, which will be reviewed by a prescribing pharmacist. If safe and suitable for you, they will prescribe Wegovy or Mounjaro, to be dispatched straight to your door
Positive progress
Alongside free, exclusive nutritional and movement plans from HANX, expect monthly follow-up consultations and a slow and steady increase in dose (titration) of your medication, if suitable
Sustaining success
You’ll see noticeable changes and be making tangible strides towards your weight loss and health goals
FAQs
This weight management programme combines a clinically proven GLP-1 medication, which is injected weekly, alongside nutritional and movement guides, to set you up to successfully meet your health goals. Wegovy and Mounjaro, which are both GLP-1 medications which are clinically proven to help people lose weight. Wegovy is the brand name for the medication ‘semaglutide’ and Mounjaro is the brand name for the medication ‘tirzepatide.’ A prescribing pharmacist will review your consultation. If they deem the medication to be safe and effective for you, they will prescribe Wegovy or Mounjaro taking into account your goals and preference.
Wegovy and Mounjaro both work by mimicking the action of the glucagon-like peptide-1 (GLP-1) hormone, which regulates your appetite. Mounjaro also mimics another hormone that regulates appetite: glucose-dependent insulinotropic polypeptide (GIP).
GLP-1 works in your brain to regulate your appetite, meaning these medications increase feelings of fullness and reduce feelings of hunger. They also reduce blood sugar by promoting the release of insulin when blood sugar levels are high.
Both Wegovy and Mounjaro come in the form of injectable pens, which you use to deliver a weekly liquid injection of medication under the skin. Make sure you read the instructions for use that come with your medication or head here for more tips on how to safely and effectively use your injection pens.
Weight management medication, including Wegovy and Mounjaro, is designed for long term use alongside lifestyle changes. It’s important that you also increase exercise and eat a balanced diet when using this medication.
Wegovy: You will start taking the lowest dose (0.25mg) once a week. You'll receive monthly check-ins to start with, to ensure you're tolerating the medication and seeing positive progress. If deemed suitable, each month, your dose of Wegovy will increase until you reach a 'maintenance' dose, at which point, we will follow-up every 3 months. If you are not tolerating the medication well, your titration will be slowed down to help your body adjust to the medication.
Mounjaro: You will start taking the lowest dose (2.5mg) once a week. You'll receive monthly check-ins to start with, to ensure you're tolerating the medication and seeing positive progress. If deemed suitable, each month, your dose of Mounjaro will increase until you reach a 'maintenance' dose, at which point, we will follow-up every 3 months. If you are not tolerating the medication well, your titration will be slowed down to help your body adjust to the medication.
A prescribing pharmacist will review your consultation. If they deem the medication to be safe and effective for you, they will prescribe Wegovy or Mounjaro, taking into account your goals and preference. Prescribing pharmacists take into account various elements including Body Mass Index (BMI) and a patient’s medical history, including the results of previous attempts at weight management.
Recent research shows that whilst semaglutide weight management medication may have an impact on symptoms of polycystic ovary syndrome in patients with obesity*. Results showed that after three months of treatment and lifestyle changes, 80% of patients saw normalised menstrual cycles, which consequently may have a positive fertility.
*Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs, National Library of Medicine, 2023
Both Wegovy and Mounjaro come in the form of injectable pens, which you use to deliver a weekly liquid injection of medication under the skin. Make sure you read the instructions for use that come with your medication or head here for more tips on how to safely and effectively use your injection pens.
Clinical studies have shown that people can lose up to 22.5% of their weight when taking Mounjaro, and up to 15% of their weight when taking Wegovy.
*Tirzepatide Once Weekly for the Treatment of Obesity, The New England Journal Of Medicine, 2022.
** Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial, Nature Medicine, 2024.
Your parcel is sent in discreet outer packaging, with an unbranded cardboard box inside.
Before your first use, store your injection pens in a refrigerator (2° C to 8° C) (making sure to keep away from the cooling element). After your first use, store below 30° C or, preferably, in a refrigerator (2° C to 8° C). Do not freeze Wegovy and do not use your medication if it has been frozen. When the pen is not in use, make sure to keep the pen cap on. Do not expose the pen to direct sunlight.
Yes, both medicines are part of The Black Triangle Scheme. The Black Triangle (▼) Scheme is a program that monitors medicines for additional safety. Wegovy and Mounjaro are part of the scheme because they are new medicines, and the scheme means patients and prescribers are encouraged to report suspected adverse drug reactions (ADRs) to the MHRA through the Yellow Card Scheme (link: https://www.gov.uk/drug-safety-update/the-black-triangle-scheme-or).
The registered healthcare provider for the Weight Management Programme is Blueco Healthcare. Medicines are prescribed by Pharmacist Independent Prescribers, you can find their details here.
Weight management medication is designed for long-term progress when teamed with lifestyle changes. You will start off taking the lowest dose of Wegovy and Mounjaro, once a week. HANX will follow up regularly with advice and guidance to help you settle into the weight management programme. You will have monthly follow-up consultations, which you'll be asked to complete to share your progress and experiences with your prescriber. If you are experiencing no major side effects, and your prescribing pharmacist deems it suitable for you, you will increase your dose of Wegovy or Mounjaro each month until you reach the most effective a 'maintenance' dose for you and check in with you regularly.
